Related Experiment Videos

[Antibiotherapy in children with atypical bacterial infections]

H Haas1

  • 1Service de pédiatrie, hôpital Archet-CHU de Nice, 151 route Saint-Antoine-de-Ginestière, 06200 Nice, France. hass.h@chu-nice.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|May 17, 2005
PubMed

Insights

Atypical bacteria like Mycoplasma pneumoniae cause frequent childhood infections. New antibiotics, especially ketolides, show promise in treating these infections and reducing complications.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Pharmacology

Context:

  • Atypical bacteria, including Mycoplasma pneumoniae and Chlamydia pneumoniae, are significant causes of respiratory infections in children.
  • Historically, atypical pneumonia in children was considered benign, with limited impact from antibiotic therapy.
  • Recent research highlights the broader role of these bacteria in various childhood infections and the potential benefits of timely treatment.

Purpose:

  • To review the role of atypical bacteria in pediatric infections.
  • To discuss the impact of antibiotic therapy on infection outcomes and complications.
  • To evaluate available antimicrobial agents, focusing on newer options like ketolides.

Summary:

  • Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila are key atypical pathogens in pediatric infections.
  • These bacteria are implicated in diverse conditions beyond pneumonia, affecting the upper airways, ears, and throat in young children.
  • Antibiotic treatment can reduce complications and recurrence rates, such as wheezing and asthma exacerbations.
  • Infections can be severe in immunocompromised children or those with underlying conditions like sickle cell anemia.
  • Choosing antibiotics requires considering activity against Streptococcus pneumoniae, especially in lower respiratory tract infections.
  • Ketolides represent a newer class of antibiotics effective against both atypical bacteria and S. pneumoniae.

Impact:

  • Highlights the evolving understanding of atypical bacterial infections in children.
  • Emphasizes the crucial role of appropriate antibiotic selection for improved patient outcomes.
  • Provides insights into the therapeutic potential of novel antibiotic classes like ketolides in pediatric care.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...